Combined therapy with L-Thyroxine and L-Triiodothyronine compared to L-Thyroxine alone in the treatment of primary hypothyroidism

Valentine V. Fadeyev, Tatyana B. Morgunova, Galina A. Melnichenko, Ivan I. Dedov

Download PDF

Objective: The objective of this study was to compare various parameters in patients with hypothyroidism receiving either monotherapy with L-Thyroxine (L-T4) or combination therapy with L-T4 and L-Triiodothyronine (L-T3). Design: We conducted a randomized, controlled trial in 36 premenopausal women with hypothyroidism …

The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients

Sayer I. Al-Azzam, Karem H. Alzoubi, Omar Khabour, Ola Al-Azzeh

Download PDF

OBJECTIVE: To investigate the possible association between response to levothyroxine (L-T4) doses in hypothyroid patients and variation in thyroid stimulating hormone receptor (TSHR) gene and thyroid hormone receptor (THRα) gene …

The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism

Baris Akinci, Abdurrahman Comlekci, Serkan Yener, Tevfik Demir, Firat Bayraktar, Faize Yuksel, Sena Yesil

Download PDF

OBJECTIVE: There is controversy as to whether hypothyroidism increases cardiovascular risk. The effect of levothyroxine on the cardiovascular risk profile is also unclear. Recent studies suggest that there is evidence of inflammation and endothelial dysfunction in hypothyroidism. Soluble CD40 ligand (sCD40L) is a protein expressed mainly by activated platelets …